ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Helping Patients with SLE Thrive

Jason Liebowitz, MD, FACR  |  July 31, 2024

Dr. Laurent Arnaud highlighted the latest information on systemic lupus erythematosus (SLE), including genetics, technology, treat to target, and promising findings for pulse therapy in his session at EULAR 2024.

Filed under:ConditionsEULAR/OtherGuidanceMeeting ReportsSystemic Lupus Erythematosus Tagged with:EULAR 2024Lupus Low Disease-Activity State (LLDAS)SLESLE Resource Centersystemic lupus erythematosus (SLE)

The Ins & Outs of Private Rheumatology Practice

Vanessa Caceres  |  July 29, 2024

For a podcast audience, Dr. Sunil Abraham shared pearls for evaluating what setting best fits you and your lifestyle, and what a career in community practice means.

Filed under:Career DevelopmentOpinionPractice SupportProfessional Topics Tagged with:ACR on AirCareerCareer developmentcommunity practicePrivate practicework-life balance

The Impact of Climate Change

Vanessa Caceres  |  July 29, 2024

Although research is still emerging, evidence suggests changes in climate, such as increases in heat, pollution and allergens, may increase the risk of flare and hospitalization in patients with rheumatoid arthritis, systemic lupus erythematosus and other rheumatic conditions. Paul Dellaripa, MD, discussed the research and how rheumatologists can help their patients.

Filed under:ConditionsRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:ACR on Airair pollutionclimate changeRheumatic Disease

FDA Approves Sarilumab for pJIA

Michele B. Kaufman, PharmD, BCGP  |  July 29, 2024

The FDA has granted sarilumab its first pediatric indication, approving the agent to treat active, polyarticular juvenile idiopathic arthritis (pJIA) in patients who weigh at least 63 kgs.

Filed under:Biologics/DMARDsConditionsDrug UpdatesPediatric Conditions Tagged with:FDA approvalpJIApolyarticular juvenile idiopathic arthritis (JIA)sarilumabU.S. Food and Drug Administration (FDA)

‘Don’t Block Patient Access to Records,’ says HHS to Healthcare Providers

From the College  |  July 17, 2024

The Department of Health & Human Services has released a final rule that would penalize healthcare providers who interfere with a patient’s access to, exchange or use of their electronic health information.

Filed under:EMRsLegal Updates Tagged with:Complianceelectronic health record (EHR)

FDA Updates Safety & Efficacy Information for Voclosporin

Michele B. Kaufman, PharmD, BCGP  |  July 10, 2024

The FDA’s latest label change for voclosporin adds data demonstrating its safety and efficacy, as well as a sustained renal response, in patients with lupus nephritis through three years of treatment.

Filed under:Biologics/DMARDsConditionsDrug UpdatesSystemic Lupus Erythematosus Tagged with:FDALabeling ChangesLupus nephritisU.S. Food and Drug Administration (FDA)voclosporin

ACR Applauds Legislation to Reform Prior Authorization Policies

From the College  |  July 9, 2024

A new bill, the Improving Seniors’ Timely Access to Care Act, aims to streamline the prior authorization process. “The prior authorization process has become unmanageable for both doctors and patients. Insurer red tape imposes a significant burden on clinicians, leading to unnecessary and unclear delays, or even outright denials of patient care,” says ACR President…

Filed under:From the CollegeLegislation & Advocacy Tagged with:Improving Seniors’ Timely Access to Care Actprior authorization

Rheum After 5: Dr. Kai Sun, a Leap Day Mom with a Leap Day Baby

Carol Patton  |  July 9, 2024

This past leap day (Feb. 29), Kai Sun, MD, MS, gave birth to her third child, a daughter named Chloe Gayoung Paik. What makes her daughter’s birth so unusual is that Dr. Sun, an assistant professor in Medicine at Duke University, Durham, NC, is also a leapling (or leaper). She was also born on Feb….

Filed under:ProfilesRheum After 5 Tagged with:Dr. Kai Sun

Case Report: Diaphragm Ultrasound Reveals Shrinking Lung Syndrome

Mery Deeb, MD, Taro Minami, MD, Michael Stanchina, MD, Elias Jabbour, MD, & Jan Karczewski, MD  |  July 9, 2024

Shrinking lung syndrome (SLS) is a rare cause of dyspnea that has been most commonly described in patients with systemic lupus erythematosus (SLE), but is also found in systemic sclerosis, Sjögren’s disease and rheumatoid arthritis. Shrinking lung syndrome is characterized by a restrictive pattern on lung spirometry, despite normal lung parenchyma, and an elevated diaphragm.1…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:case reportdyspneashrinking lung syndromeSLE Resource CenterUltrasound

Consensus Guidelines on Diagnostic Approach to Giant Cell Arteritis Arrive from Society for Cardiovascular Pathology

Moayad Alqazlan, MBBS, Vidhya Nair, MBBS, MD, & Michael A. Seidman, MD, PhD  |  July 9, 2024

At the end of 2023, the Society for Cardiovascular Pathology (SCVP) published consensus guidelines on the diagnostic approach to temporal artery biopsy.1 Through this publication, SCVP hopes to bring more uniformity to the processing, interpretation and reporting of these specimens, taking into consideration the most up-to-date literature available. These guidelines have obvious impact on clinical…

Filed under:Clinical Criteria/GuidelinesConditionsOpinionSpeak Out RheumVasculitis Tagged with:Giant Cell Arteritisgiant cell arteritis (GCA)temporal artery biopsy

  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 328
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences